Description: ViaDerma, Inc. is a pharmaceutical company focused on bringing new products to the pharmaceutical industry through research and development. The Company licenses and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company's products are applied topically using a delivery system technology. The Company's products are used within the over-the-counter (OTC) drug market. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies. The Company has products in development in various fields, including topical antibiotics (TetraStem), topical anti-viral product (Viralcur) for genital herpes, anti-fungal products for onychomycocis (OnyPro), hair loss prevention product (HairGain), skin cancer therapies (Cantrile), and a topical stem cell therapy product (TetraStem Plus).
Home Page: viadermalicensing.com
4640 Admiralty Way
Marina del Rey,
CA
90292
United States
Phone:
310 496 5744
Officers
| Name | Title |
|---|---|
| Mr. Qing Hua Lin | Chief Financial Officer and Director |
| Mr. Baotang Zhao | Chief Sales Officer |
| Mr. Zhang Xie | Corp. Sec. and Director |
| Mr. Shaowen Zhang | Mang. of Production |
| Dr. Christopher A Otiko | Founder, Chief Exec. Officer and Pres |
| Dr. Andrew Berman M.D., MPH | Medical Director and Member of Advisory Board |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.0373 |
| Price-to-Book MRQ: | 0.0024 |
| Price-to-Sales TTM: | 2.0072 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |